Team | Year | Pos | G | IP | PO | A | E | Fld % | RF | Eff | Frm | Arm | ZR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Philadelphia - ML
PHI - ML
|
2044 | 2B | 2 | 3.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | - | - | 0.00 |
Philadelphia - ML
PHI - ML
|
2044 | 3B | 1 | 1.0 | 0 | 1 | 0 | 1.000 | 9.00 | 1.026 | - | - | 0.03 |
Philadelphia - ML
PHI - ML
|
2044 | CF | 8 | 24.2 | 8 | 1 | 0 | 1.000 | 3.28 | .902 | - | 0.0 | -0.67 |
Philadelphia - ML
PHI - ML
|
2044 | RF | 116 | 988.1 | 207 | 6 | 0 | 1.000 | 1.94 | 1.020 | - | 0.0 | 3.08 |
Philadelphia - ML
PHI - ML
|
2043 | 2B | 2 | 4.0 | 0 | 1 | 0 | 1.000 | 2.25 | 1.040 | - | - | 0.02 |
Philadelphia - ML
PHI - ML
|
2043 | 3B | 20 | 55.1 | 1 | 12 | 0 | 1.000 | 2.11 | 1.037 | - | - | 0.33 |
Philadelphia - ML
PHI - ML
|
2043 | SS | 1 | 1.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | - | - | 0.00 |
Philadelphia - ML
PHI - ML
|
2043 | LF | 8 | 17.2 | 4 | 0 | 0 | 1.000 | 2.04 | .795 | - | 0.0 | -0.79 |
Philadelphia - ML
PHI - ML
|
2043 | CF | 9 | 43.2 | 14 | 0 | 0 | 1.000 | 2.89 | 1.085 | - | 0.0 | 0.86 |
Philadelphia - ML
PHI - ML
|
2043 | RF | 99 | 845.1 | 187 | 5 | 1 | .995 | 2.04 | 1.068 | - | 0.0 | 9.02 |
Total | 2B | 4 | 7.0 | 0 | 1 | 0 | - | - | - | - | - | 0.02 | |
Total | 3B | 21 | 56.1 | 1 | 13 | 0 | - | - | - | - | - | 0.36 | |
Total | SS | 1 | 1.0 | 0 | 0 | 0 | - | - | - | - | - | 0.00 | |
Total | LF | 8 | 17.2 | 4 | 0 | 0 | - | - | - | - | 0.0 | -0.79 | |
Total | CF | 17 | 68.1 | 22 | 1 | 0 | - | - | - | - | 0.0 | 0.20 | |
Total | RF | 215 | 1833.2 | 394 | 11 | 1 | - | - | - | - | 0.0 | 12.11 |